The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting

By                    

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1418-1426

Spandidos Publications

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite

Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population

By Tian Weihua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 71-78

Humana Press, Inc

Access to resources Recommend Favorite

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

By Choi Chel   Kim Min   Park Jin-Young   Yoon Aera   Kim Ha-Jeong   Lee Yoo-Young   Kim Tae-Joong   Lee Jeong-Won   Kim Byoung-Gie   Bae Duk-Soo  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1181-1187

Springer Publishing Company

Access to resources Recommend Favorite

The cost of chemotherapy-induced nausea and vomiting in Italy

By Ballatori Enzo   Roila Fausto   Ruggeri Benedetta   Porrozzi Stella   Iannopollo Mauro   Soru Giancarla   Cruciani Giorgio   Daniele Bruno   Locatelli Maria   Pellissier James   Deuson Robert  

Supportive Care in Cancer, Vol. 15, Iss. 1, 2007-01 ,pp. : 31-38

Springer Publishing Company

Access to resources Recommend Favorite